Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
ATP2A2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Mendelian Disorders with Psychiatric Symptoms Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 254 | 166 |
|
Darier-White disease Comprehensive HNL Genomics Connective Tissue Gene Tests United States | 1 | 1 |
|
Darier-White disease Deletion / Duplication HNL Genomics Connective Tissue Gene Tests United States | 1 | 1 |
|
HNL Genomics Connective Tissue Gene Tests United States | 1 | 1 |
|
X-chromosome High Resolution microarray analysis Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center United States | 240 | 171 |
|
Darier disease: Full gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 2 | 1 |
|
Fulgent Genetics United States | 354 | 210 |
|
Adolescent/Adult Epilepsy NGS Panel Fulgent Genetics United States | 182 | 82 |
|
Darier Disease (ATP2A2 Single Gene Test) Fulgent Genetics United States | 2 | 1 |
|
Epilepsy Advanced Sequencing and CNV Evaluation - Syndromic Disorders Athena Diagnostics United States | 30 | 31 |
|
Epilepsy Advanced Sequencing and CNV Evaluation Athena Diagnostics United States | 235 | 234 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
Epilepsy Comprehensive NGS Panel Fulgent Genetics United States | 729 | 398 |
|
Bioarray Spain | 1 | 1 |
|
CeGaT GmbH Germany | 2 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.